Agile Therapeutics Inc.

NASDAQ: AGRX · Real-Time Price · USD
1.51
0.05 (3.42%)
At close: Aug 22, 2024, 9:58 PM

Agile Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-14.46M -25.41M -74.89M
Depreciation & Amortization
386K 1.53M 2.22M
Stock-Based Compensation
1.98M 2.49M 3.34M
Other Working Capital
9.64M 705K -1.1M
Other Non-Cash Items
1.06M -12.43M 1.66M
Deferred Income Tax
-5.96M n/a 5.32M
Change in Working Capital
7.42M -2.13M -2.85M
Operating Cash Flow
-9.58M -35.95M -65.2M
Capital Expenditures
n/a -133K -269K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a 39.73M
Other Investing Acitivies
n/a -133K 39.73M
Investing Cash Flow
n/a -133K 39.46M
Debt Repayment
-1.35M -17.38M n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
15.29M n/a 75K
Financial Cash Flow
6.89M 22.18M 30.42M
Net Cash Flow
-2.69M -13.9M 4.68M
Free Cash Flow
-9.58M -36.08M -65.47M